Pharmaceutical Logistics Market Size

Pharmaceutical Logistics Market size was valued at USD 85.24 Billion in 2023 and is poised to grow from USD 93.08 Billion in 2024 to USD 185.83 Billion by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).

Pharma companies constantly undertake strategic initiatives, such as mergers and acquisitions, to maintain their market position. FedEx, for example, acquired Manton Air-Sea Pty Ltd., a logistics service provider, in October 2018. FedEx's geographical footprint in the Asia Pacific region was strengthened as a result of the acquisition. 'DHL Global Forwarding ', 'FedEx Corporation ', 'DB Schenker ', 'Kuehne + Nagel ', 'Penske Logistics ', 'Cardinal Health ', 'UPS Healthcare ', 'Rhenus Logistics ', 'XPO Logistics ', 'Hellmann Worldwide Logistics ', 'Expeditors International ', 'Nippon Express ', 'DSV ', 'PSA International ', 'Walden Group ', 'Maersk '

Need to maintain cold chain integrity for pharmaceutical products while lowering distribution costs by creating a single source distribution channel is driving up demand for pharmaceutical logistics.

In pharmaceutical logistics, products are GPS tracked as well as remotely monitored temperature in accordance with GDP guidelines, ensuring safe transportation and delivery of the products. Additional precautions are taken to ensure the safe delivery of narcotics and pharmaceutical products. Different delivery patterns are used for different types of pharmaceuticals. Stringent reimbursement, regulations, direct sell models, pricing applied by government agencies, third-party logistics, product diversity, shipment of R&D products for clinical studies, difficulty forecasting a product's lifecycle, and counterfeit products are all issues in pharmaceutical supply chains.

Europe had a market share of more than 36.0% in 2021 and is expected to grow at a significant rate from 2022 to 2030. The significant growth in pharmaceutical product trades across key European countries is responsible for the high market share. These countries primarily include Germany, the United Kingdom, France, the Nordic countries, and others. Furthermore, growing domestic production and demand for several categories of pharma products, such as OTC medicines, has aided the market in gaining a sizable market share.